SEC Filings for Novartis AG (NVS)

$ 87.01   -0.33 (-0.38%) Volume: 1.19m 7:00 PM EDT 10-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
4Statement of changes in beneficial ownership of securities107/02/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934507/02/2020
3Initial statement of beneficial ownership of securities206/25/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934506/25/2020
4Statement of changes in beneficial ownership of securities106/22/2020
3Initial statement of beneficial ownership of securities206/18/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934606/17/2020
4Statement of changes in beneficial ownership of securities106/17/2020
4Statement of changes in beneficial ownership of securities106/12/2020
4Statement of changes in beneficial ownership of securities106/09/2020
4Statement of changes in beneficial ownership of securities106/04/2020
SDSpecialized Disclosure Report806/01/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934805/12/2020
S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments304/30/2020
S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments304/30/2020
<<
First
<
Prev
123456789101112131415